ASH Abstract commends FerriScan as "crucial"
- 15 January 2015
A recent abstract from the American Society of Hematology has demonstrated the importance of FerriScan in the management of patients with hemoglobinopathies.
FerriScan And Cardiac T2* Services Showcased In Europe
- 22 December 2014
Resonance Health exhibited at the Thalassaemia International Federation (TIF) conference in Athens and the UK Forum in London to profile FerriScan and Cardiac T2* services to over 600 delegates from Europe.
Resonance Health exhibits at AASLD - the world's largest meeting of liver specialists
- 20 November 2014
Resonance Health attended and exhibited at the American Association for the Study of Liver Disease (AASLD) conference in Boston on the 7-11 November.
Resonance Health - 2014 WA Innovator of the Year Overall Winner
- 06 November 2014
Resonance Health tackles growing prevalence of fatty liver disease and is awarded the 2014 WA Innovator of the Year Overall Winner for HepaFat-Scan
Resonance Health is Exhibiting at BASL
- 18 September 2014
Resonance Health is excited to be exhibiting at the Annual Meeting of the British Association for the Study of the Liver in England this week - 14th - 18th September 2014.